New subtype of ovarian cancer may be vulnerable to anti-angiogenic drugs

BOSTON--Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to "anti-angiogenic" drugs that block blood vessel formation.

Read the whole article on Physorg

More from Physorg